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I
n clinical epidemiological research, 
errors occur in spite of careful 
study design, conduct, and 
implementation of error-prevention 
strategies. Data cleaning intends to 
identify and correct these errors or at 
least to minimize their impact on study 
results. Little guidance is currently 
available in the peer-reviewed literature 
on how to set up and carry out cleaning 
efforts in an efﬁ  cient and ethical 
way. With the growing importance 
of Good Clinical Practice guidelines 
and regulations, data cleaning and 
other aspects of data handling will 
emerge from being mainly gray-
literature subjects to being the focus 
of comparative methodological 
studies and process evaluations. 
We present a brief summary of the 
scattered information, integrated into 
a conceptual framework aimed at 
assisting investigators with planning 
and implementation. We recommend 
that scientiﬁ  c reports describe data-
cleaning methods, error types and 
rates, error deletion and correction 
rates, and differences in outcome with 
and without remaining outliers.
The History of Data Cleaning
With Good Clinical Practice guidelines 
being adopted and regulated in more 
and more countries, some important 
shifts in clinical epidemiological 
research practice can be expected. One 
of the expected developments is an 
increased emphasis on standardization, 
documentation, and reporting of data 
handling and data quality. Indeed, 
in scientiﬁ  c tradition, especially in 
academia, study validity has been 
discussed predominantly with regard 
to study design, general protocol 
compliance, and the integrity and 
experience of the investigator. Data 
handling, although having an equal 
potential to affect the quality of study 
results, has received proportionally 
less attention. As a result, even though 
the importance of data-handling 
procedures is being underlined in good 
clinical practice and data management 
guidelines [1–3], there are important 
gaps in knowledge about optimal data-
handling methodologies and standards 
of data quality. The Society for Clinical 
Data Management, in their guidelines 
for good clinical data management 
practices, states: “Regulations and 
guidelines do not address minimum 
acceptable data quality levels for clinical 
trial data. In fact, there is limited 
published research investigating the 
distribution or characteristics of clinical 
trial data errors. Even less published 
information exists on methods of 
quantifying data quality” [4].
Data cleaning is emblematic of the 
historical lower status of data quality 
issues and has long been viewed as 
a suspect activity, bordering on data 
manipulation. Armitage and Berry 
[5] almost apologized for inserting 
a short chapter on data editing in 
their standard textbook on statistics 
in medical research. Nowadays, 
whenever discussing data cleaning, 
it is still felt to be appropriate to 
start by saying that data cleaning 
can never be a cure for poor study 
design or study conduct. Concerns 
about where to draw the line between 
data manipulation and responsible 
data editing are legitimate. Yet all 
studies, no matter how well designed 
and implemented, have to deal with 
errors from various sources and their 
effects on study results. This problem 
occurs as much to experimental as to 
observational research and clinical trials 
[6,7]. Statistical societies recommend 
that description of data cleaning be a 
standard part of reporting statistical 
methods [8]. Exactly what to report 
and under what circumstances remains 
mostly unanswered. In practice, it is 
rare to ﬁ  nd any statements about data-
cleaning methods or error rates in 
medical publications. 
Although certain aspects of data 
cleaning such as statistical outlier 
detection and handling of missing 
data have received separate attention 
[9–18], the data-cleaning process, 
as a whole, with all its conceptual, 
organizational, logistical, managerial, 
and statistical-epidemiological 
aspects, has not been described 
or studied comprehensively. In 
statistical textbooks and non-peer-
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Box 1. Terms Related to Data 
Cleaning
Data cleaning: Process of detecting, 
diagnosing, and editing faulty data.
Data editing: Changing the value of data 
shown to be incorrect.
Data ﬂ  ow: Passage of recorded 
information through successive 
information carriers. 
Inlier: Data value falling within the 
expected range.
Outlier: Data value falling outside the 
expected range.
Robust estimation: Estimation of 
statistical parameters, using methods that 
are less sensitive to the effect of outliers 
than more conventional methods.
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reviewed literature, there is scattered 
information, which we summarize in 
this paper, using the concepts and 
deﬁ  nitions shown in Box 1. 
The complete process of quality 
assurance in research studies includes 
error prevention, data monitoring, data 
cleaning, and documentation. There 
are proposed models that describe 
total quality assurance as an integrated 
process [19]. However, we concentrate 
here on data cleaning and, as a second 
aim of the paper, separately describe a 
framework for this process. Our focus 
is primarily on medical research and 
on practical relevance for the medical 
investigator.
Data Cleaning as a Process
Data cleaning deals with data problems 
once they have occurred. Error-
prevention strategies can reduce many 
problems but cannot eliminate them. 
We present data cleaning as a three-
stage process, involving repeated cycles 
of screening, diagnosing, and editing 
of suspected data abnormalities. Figure 
1 shows these three steps, which can 
be initiated at three different stages 
of a study. Many data errors are 
detected incidentally during study 
activities other than data cleaning. 
However, it is more efﬁ  cient to 
detect errors by actively searching 
for them in a planned way. It is not 
always immediately clear whether a 
data point is erroneous. Many times, 
what is detected is a suspected data 
point or pattern that needs careful 
examination. Similarly, missing values 
require further examination. Missing 
values may be due to interruptions 
of the data ﬂ  ow or the unavailability 
of the target information. Hence, 
predeﬁ  ned rules for dealing with errors 
and true missing and extreme values 
are part of good practice. One can 
screen for suspect features in survey 
questionnaires, computer databases, 
or analysis datasets. In small studies, 
with the investigator closely involved 
at all stages, there may be little or no 
distinction between a database and an 
analysis dataset. 
The diagnostic and treatment phases 
of data cleaning require insight into 
the sources and types of errors at all 
stages of the study, during as well as 
after measurement. The concept of 
data ﬂ  ow is crucial in this respect. After 
measurement, research data undergo 
repeated steps of being entered 
into information carriers, extracted, 
transferred to other carriers, edited, 
selected, transformed, summarized, 
and presented. It is important to realize 
that errors can occur at any stage of 
the data ﬂ  ow, including during data 
cleaning itself. Table 1 illustrates some 
of the sources and types of errors 
possible in a large questionnaire survey. 
Most problems are due to human error.
Inaccuracy of a single measurement 
and data point may be acceptable, 
and related to the inherent technical 
error of the measurement instrument. 
Hence, data cleaning should focus 
on those errors that are beyond small 
technical variations and that constitute 
a major shift within or beyond the 
population distribution. In turn, data 
cleaning must be based on knowledge 
of technical errors and expected ranges 
of normal values. 
Some errors deserve priority, but 
which ones are most important is 
highly study-speciﬁ  c. In most clinical 
epidemiological studies, errors that 
need to be cleaned, at all costs, include 
missing sex, sex misspeciﬁ  cation, 
birth date or examination date errors, 
duplications or merging of records, 
and biologically impossible results. 
For example, in nutrition studies, date 
errors lead to age errors, which in turn 
lead to errors in weight-for-age scoring 
and, further, to misclassiﬁ  cation of 
subjects as under- or overweight.
Errors of sex and date are 
particularly important because 
they contaminate derived variables. 
Prioritization is essential if the study is 
under time pressures or if resources for 
data cleaning are limited. 
Screening Phase 
When screening data, it is convenient 
to distinguish four basic types of 
oddities: lack or excess of data; outliers, 
including inconsistencies; strange 
patterns in (joint) distributions; and 
unexpected analysis results and other 
types of inferences and abstractions 
(Table 1). Screening methods need 
not only be statistical. Many outliers are 
detected by perceived nonconformity 
with prior expectations, based on 
the investigator’s experience, pilot 
studies, evidence in the literature, or 
common sense. Detection may even 
happen during article review or after 
publication. 
What can be done to make screening 
objective and systematic? To allow the 
researcher to understand the data 
better, it should be examined with 
simple descriptive tools. Standard 
statistical packages or even spreadsheets 
make this easy to do [20,21]. For 
identifying suspect data, one can ﬁ  rst 
predeﬁ  ne expectations about normal 
ranges, distribution shapes, and strength 
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Figure 1. A Data-Cleaning Framework 
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of relationships [22]. Second, the 
application of these criteria can be 
planned beforehand, to be carried out 
during or shortly after data collection, 
during data entry, and regularly 
thereafter. Third, comparison of the 
data with the screening criteria can be 
partly automated and lead to ﬂ  agging of 
dubious data, patterns, or results. 
A special problem is that of erroneous 
inliers, i.e., data points generated by 
error but falling within the expected 
range. Erroneous inliers will often 
escape detection. Sometimes, inliers 
are discovered to be suspect if viewed in 
relation to other variables, using scatter 
plots, regression analysis, or consistency 
checks [23]. One can also identify some 
by examining the history of each data 
point or by remeasurement, but such 
examination is rarely feasible. Instead, 
one can examine and⁄or remeasure a 
sample of inliers to estimate an error 
rate [24]. Useful screening methods are 
listed in Box 2.
Diagnostic Phase
In this phase, the purpose is to clarify 
the true nature of the worrisome data 
points, patterns, and statistics. Possible 
diagnoses for each data point are as 
follows: erroneous, true extreme, true 
normal (i.e, the prior expectation 
was incorrect), or idiopathic (i.e., no 
explanation found, but still suspect). 
Some data points are clearly logically 
or biologically impossible. Hence, 
one may predeﬁ  ne not only screening 
cutoffs as described above (soft 
cutoffs), but also cutoffs for immediate 
diagnosis of error (hard cutoffs) 
[10]. Figure 2 illustrates this method. 
Sometimes, suspected errors will fall in 
between the soft and hard cutoffs, and 
diagnosis will be less straightforward. 
In these cases, it is necessary to apply a 
combination of diagnostic procedures. 
One procedure is to go to previous 
stages of the data ﬂ  ow to see whether 
a value is consistently the same. This 
requires access to well-archived and 
documented data with justiﬁ  cations 
for any changes made at any stage. 
A second procedure is to look for 
information that could conﬁ  rm the 
true extreme status of an outlying data 
point. For example, a very low score for 
weight-for-age (e.g., −6 Z-scores) might 
be due to errors in the measurement 
of age or weight, or the subject may be 
extremely malnourished, in which case 
other nutritional variables should also 
have extremely low values. Individual 
patients’ reports with accumulated 
information on related measurements 
are helpful for this purpose. This type 
of procedure requires insight into the 
coherence of variables in a biological 
or statistical sense. Again, such insight 
is usually available before the study 
and can be used to plan and program 
data cleaning. A third procedure is to 
collect additional information, e.g., 
question the interviewer⁄measurer 
about what may have happened and, 
if possible, repeat the measurement. 
Such procedures can only happen 
if data cleaning starts soon after 
data collection, and sometimes 
remeasuring is only valuable very 
shortly after the initial measurement. 
In longitudinal studies, variables are 
often measured at speciﬁ  c ages or 
follow-up times. With such designs, 
the possibility of remeasuring or 
obtaining measurements for missing 
data will often be limited to predeﬁ  ned 
allowable intervals around the target 
times. Such intervals can be set wider 
if the analysis foresees using age or 
follow-up time as a continuous variable. 
Finding an acceptable value does 
not always depend on measuring or 
remeasuring. For some input errors, 
the correct value is immediately 
obvious, e.g., if values of infant length 
are noted under head circumference 
and vice versa. This example again 
illustrates the usefulness of the 
investigator’s subject-matter knowledge 
in the diagnostic phase. Substitute 
code values for missing data should be 
corrected before analysis. 
During the diagnostic phase, one may 
have to reconsider prior expectations 
and⁄or review quality assurance 
procedures. The diagnostic phase is 
labor intensive and the budgetary, 
logistical, and personnel requirements 
are typically underestimated or even 
neglected at the study design stage. 
How much effort must be spent? 
Cost-effectiveness studies are needed 
to answer this question. Costs may 
be lower if the data-cleaning process 
is planned and starts early in data 
collection. Automated query generation 
and automated comparison of 
successive datasets can be used to lower 
costs and speed up the necessary steps. 
Treatment Phase
After identiﬁ  cation of errors, missing 
values, and true (extreme or normal) 
values, the researcher must decide what 
to do with problematic observations. 
The options are limited to correcting, 
deleting, or leaving unchanged. There 
are some general rules for which 
option to choose. Impossible values 
are never left unchanged, but should 
be corrected if a correct value can 
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Table 1. Issues to Be Considered during Data Collection, Management, and Analysis of a Questionnaire Study
Data Stage Sources of Problems: Lack or Excess of Data Sources of Problems: Outliers and Inconsistencies
Questionnaire Form missing Correct value ﬁ  lled out in wrong box
Form double, collected repeatedly Not readable
Answering box or options list left blank Writing error
More than one option selected when not allowed Answer given is out of expected (conditional) range
Database Lack or excess of data carried over from questionnaire Outliers and inconsistencies carried over from questionnaire
Form or ﬁ  eld not entered Value incorrectly entered
Data erroneously entered twice Value incorrectly changed during previous data cleaning
Value entered in wrong ﬁ  eld Transformation (programming) error
Inadvertent deletions and duplications during database handling
Analysis dataset Lack or excess of data carried over from database Outliers and inconsistencies carried over from database
Data extraction or transfer error Data extraction or transfer error
Deletions or duplications by analyst Sorting errors (spreadsheets)
Data-cleaning errors
DOI: 10.1371/journal.pmed.0020267.t001PLoS Medicine  |  www.plosmedicine.org 0969
be found, otherwise they should be 
deleted. For biological continuous 
variables, some within-subject variation 
and small measurement variation is 
present in every measurement. If a 
remeasurement is done very rapidly 
after the initial one and the two values 
are close enough to be explained by 
these small variations alone, accuracy 
may be enhanced by taking the average 
of both as the ﬁ  nal value. 
What should be done with true 
extreme values and with values that 
are still suspect after the diagnostic 
phase? The investigator may wish 
to further examine the inﬂ  uence of 
such data points, individually and as 
a group, on analysis results before 
deciding whether or not to leave the 
data unchanged. Statistical methods 
exist to help evaluate the inﬂ  uence 
of such data points on regression 
parameters. Some authors have 
recommended that true extreme 
values should always stay in the analysis 
[25]. In practice, many exceptions are 
made to that rule. The investigator 
may not want to consider the effect 
of true extreme values if they result 
from an unanticipated extraneous 
process. This becomes an a posteriori 
exclusion criterion and the data points 
should be reported as “excluded from 
analysis”. Alternatively, it may be that 
the protocol-prescribed exclusion 
criteria were inadvertently not applied 
in some cases [26]. 
Data cleaning often leads to insight 
into the nature and severity of error-
generating processes. The researcher 
can then give methodological feedback 
to operational staff to improve study 
validity and precision of outcomes. It 
may be necessary to amend the study 
protocol, regarding design, timing, 
observer training, data collection, 
and quality control procedures. In 
extreme cases, it may be necessary to 
restart the study. Programming of data 
capture, data transformations, and data 
extractions may need revision, and the 
analysis strategy should be adapted 
to include robust estimation or to do 
separate analyses with and without 
remaining outliers and⁄or with and 
without imputation.
Data Cleaning as a Study-
Speciﬁ  c Process
The sensitivity of the chosen statistical 
analysis method to outlying and missing 
values can have consequences in terms 
of the amount of effort the investigator 
wants to invest to detect and remeasure. 
It also inﬂ  uences decisions about what 
to do with remaining outliers (leave 
unchanged, eliminate, or weight during 
analysis) and with missing data (impute 
or not) [27–31]. Study objectives 
codetermine the required precision of 
the outcome measures, the error rate 
that is acceptable, and, therefore, the 
necessary investment in data cleaning. 
Longitudinal studies necessitate 
checking the temporal consistency 
of data. Plots of serial individual 
data such as growth data or repeated 
measurements of categorical variables 
often show a recognizable pattern from 
which a discordant data point clearly 
stands out. In clinical trials, there 
may be concerns about investigator 
bias resulting from the close data 
inspections that occur during cleaning, 
so that examination by an independent 
expert may be needed.
In small studies, a single outlier will 
have a greater distorting effect on the 
results. Some screening methods such 
as examination of data tables will be 
more effective, whereas others, such 
as statistical outlier detection, may 
become less valid with smaller samples. 
The volume of data will be smaller; 
hence, the diagnostic phase can be 
cheaper and the whole procedure 
more complete. Smaller studies usually 
involve fewer people, and the steps 
in the data ﬂ  ow may be fewer and 
more straightforward, allowing fewer 
opportunities for errors. 
In intervention studies with interim 
evaluations of safety or efﬁ  cacy, it is of 
particular importance to have reliable 
data available before the evaluations 
take place. There is a need to initiate 
and maintain an effective data-cleaning 
process from the start of the study.
Documentation and Reporting
Good practice guidelines for data 
management require transparency 
and proper documentation of all 
procedures [1–4,30]. Data cleaning, as 
an essential aspect of quality assurance 
and a determinant of study validity, 
should not be an exception. We suggest 
including a data-cleaning plan in study 
protocols. This plan should include 
budget and personnel requirements, 
prior expectations used to screen 
suspect data, screening tools, diagnostic 
procedures used to discern errors from 
true values, and the decision rules that 
will be applied in the editing phase. 
Box 2. Screening Methods
• Checking of questionnaires using ﬁ  xed 
algorithms.
• Validated data entry and double data 
entry.
• Browsing of data tables after sorting.
• Printouts of variables not passing 
range checks and of records not passing 
consistency checks.
• Graphical exploration of distributions: 
box plots, histograms, and scatter plots.
• Plots of repeated measurements on the 
same individual, e.g., growth curves.
• Frequency distributions and cross-
tabulations.
• Summary statistics.
• Statistical outlier detection.
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Figure 2. Areas within the Range of a Continuous Variable Deﬁ  ned by Hard and Soft Cutoffs 
for Error Screening and Diagnosis, with Recommended Diagnostic Steps for Data Points 
Falling in Each Area
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Proper documentation should exist for 
each data point, including differential 
ﬂ  agging of types of suspected 
features, diagnostic information, and 
information on type of editing, dates, 
and personnel involved.
In large studies, data-monitoring 
and safety committees should receive 
detailed reports on data cleaning, and 
procedural feedbacks on study design 
and conduct should be submitted to a 
study’s steering and ethics committees. 
Guidelines on statistical reporting of 
errors and their effect on outcomes 
in large surveys have been published 
[31]. We recommend that medical 
scientiﬁ  c reports include data-
cleaning methods. These methods 
should include error types and rates, 
at least for the primary outcome 
variables, with the associated deletion 
and correction rates, justiﬁ  cation 
for imputations, and differences in 
outcome with and without remaining 
outliers [25].  
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